ANAB
$18.87
Revenue | $9.01Mn |
Net Profits | $-42.21Mn |
Net Profit Margins | -468.75% |
Anaptysbio Inc’s revenue jumped 32.27% since last year same period to $9.01Mn in the Q4 2023. On a quarterly growth basis, Anaptysbio Inc has generated 171.4% jump in its revenue since last 3-months.
Anaptysbio Inc’s net profit fell -59.81% since last year same period to $-42.21Mn in the Q4 2023. On a quarterly growth basis, Anaptysbio Inc has generated -13.14% fall in its net profits since last 3-months.
Anaptysbio Inc’s net profit margin fell -20.82% since last year same period to -468.75% in the Q4 2023. On a quarterly growth basis, Anaptysbio Inc has generated 58.31% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -1.56 |
EPS Estimate Current Year | -1.56 |
Anaptysbio Inc’s earning per share (EPS) estimates for the current quarter stand at -1.56 - a 2.5% jump from last quarter’s estimates.
Anaptysbio Inc’s earning per share (EPS) estimates for the current year stand at -1.56.
Earning Per Share (EPS) | -1.59 |
Anaptysbio Inc’s earning per share (EPS) fell -70.97% since last year same period to -1.59 in the Q4 2023. This indicates that the Anaptysbio Inc has generated -70.97% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-11-02 | -1.79 | -1.41 | 21.23% |
2023-05-11 | -1.05 | -1.58 | -50.48% |
2023-08-07 | -1.7 | -1.5 | 11.76% |
2024-03-11 | -1.6 | -1.59 | 0.63% |